Solventum Corp reported $3.74B in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Abbott USD 25.51B 488M Mar/2026
Align Technology USD 2.66B 7.62M Jun/2026
Baxter International USD 6.99B 142M Jun/2026
Becton, Dickinson and Co. USD 8.14B 127M Jun/2026
Cencora USD 53.14B 1.01B Mar/2026
Dexcom USD 4.09B 245.1M Jun/2026
Insulet USD 1.85B 139.6M Jun/2026
Solventum Corp USD 3.74B 158M Jun/2026
West Pharmaceutical Services USD 1.81B 19.3M Jun/2026
Zimmer Biomet Holdings USD 5.1B 134.2M Jun/2026